[Use of a new interferon inducer and leukocyte interferon for a significant enhancement of the immunocytotherapy of leukemia in mice].
D000818:Animals; D002460:Cell Line; D003520:Cyclophosphamide / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D003602:Cytotoxicity, Immunologic; D007167:Immunotherapy; D007370:Interferon Type I / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology*; D007939:Leukemia L1210 / Q000276:immunology / Q000628:therapy; D007942:Leukemia, Experimental / Q000276:immunology / Q000628:therapy*; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011070:Poly I-C / Q000276:immunology*; D013154:Spleen / Q000637:transplantation
D007370:Interferon Type I; D003520:Cyclophosphamide; D011070:Poly I-C
Ispol'zovanie novogo interferonogena i leĭkotsitarnogo interferona dlia sushchestvennogo usileniia éffekta immunotsitoterapii leĭkozov u mysheĭ.